Docket Number:12A-1020104
Inventor:Cathy SJ Fann, Tien-Chun Chang, Wei-Shiung Yang, Pei-Lung Chen, Ai-Ru Hsieh, Yuan Tsong Chen, Jer-Yuarrn Wu, Chen-Chung Chu
IP Status:TW I518538、CN pending
Abstract:
Genetic variation associated with human leukocyte antigen (HLA) alleles has immunological functions and is associated with autoimmune diseases and some cancers. To date, large scale studies involving classical HLA alleles have been limited because time-consuming and expensive HLA-typing technologies. One classical HLA allele typing needs about $1500~$2000/individual (Transnational Medicine and Pharmacogenomic Center), however, one SNP typing only requires $15~$20/individual (National Center for Genome Medicine). To reduce the cost, single-nucleotide polymorphisms (SNPs) have been used to predict HLA-allele types. In our study, around 20 SNPs are needed to predict a classical HLA allele accurately, therefore, the cost is down to 1/10 compared with using HLA technology. Although HLA allelic distributions differ among populations, most HLA-predictive models are based on Caucasian samples, with few reported studies involving non-Caucasians. Zhang et al. (2011) emphasized that predictive accuracies were poor if HLA alleles from non-Caucasian subjects were used as the training data set to build predictive HLA models for different ethnic groups. Hence, the African-specific HLA-predictive model has been developed [Ayele et al. 2012]. Since there is no information concerning HLA alleles in Han Chinese populations, we applied the Li et al. (2011) method to Han Chinese samples from Taiwan to build ethnic-specific HLA-predictive models for Han Chinese populations. We produced a set of SNPs that can best predict the HLA alleles for Major histocompatibility complex (MHC) class I (HLA-A, HLA-B, and HLA-C) and MHC class II (HLA-DR, HLA-DQ and HLA-DP) alleles.
Fields of Application:
The invention is for Han Chinese population that can be applied to Bone Marrow Donor Worldwide. In the next procedure, we plan to predict HLA loci using SNP markers. These predicted HLA loci can be used to calculate the risk of some genetic complex diseases such as Grave disease
Advantages when compared to the existing technologies:
Recent advances in array-based SNP genotyping technologies have led to a revolution in the nature and scale of disease-association studies. These developed technologies yield economical ways to genotype one million SNPs across the entire genome in large-population studies. To date, direct experimental methods for typing HLA alleles (via serology or PCR) remain laborious, expensive, and time consuming. As such, the use of chip data may represent an alternative method for constructing HLA-predictive models.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
